Phibro Animal Health (NASDAQ:PAHC) Stock Rating Lowered by StockNews.com

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) was downgraded by equities researchers at StockNews.com from a "strong-buy" rating to a "buy" rating in a research report issued on Thursday.

PAHC has been the subject of a number of other reports. Barclays upped their price target on Phibro Animal Health from $13.00 to $20.00 and gave the stock an "underweight" rating in a report on Tuesday, November 12th. Morgan Stanley increased their price target on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an "equal weight" rating in a report on Tuesday, December 17th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat.com, Phibro Animal Health currently has an average rating of "Hold" and an average price target of $21.00.

Phibro Animal Health Stock Performance

NASDAQ:PAHC traded up $2.53 during midday trading on Thursday, reaching $26.22. The stock had a trading volume of 810,065 shares, compared to its average volume of 181,513. The stock has a market capitalization of $1.06 billion, a P/E ratio of 54.62, a PEG ratio of 0.53 and a beta of 0.52. Phibro Animal Health has a 1-year low of $11.24 and a 1-year high of $26.42. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.69. The firm's fifty day simple moving average is $21.90 and its 200-day simple moving average is $21.70.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. On average, equities research analysts forecast that Phibro Animal Health will post 1.94 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Quantbot Technologies LP acquired a new position in shares of Phibro Animal Health in the 3rd quarter valued at $70,000. nVerses Capital LLC acquired a new position in Phibro Animal Health in the third quarter worth about $70,000. China Universal Asset Management Co. Ltd. lifted its stake in Phibro Animal Health by 63.7% during the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company's stock worth $88,000 after purchasing an additional 1,522 shares during the period. New York State Teachers Retirement System boosted its holdings in Phibro Animal Health by 16.7% during the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock valued at $114,000 after purchasing an additional 775 shares in the last quarter. Finally, CWM LLC grew its stake in shares of Phibro Animal Health by 190.8% in the 3rd quarter. CWM LLC now owns 6,363 shares of the company's stock valued at $143,000 after purchasing an additional 4,175 shares during the period. 99.34% of the stock is owned by institutional investors.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.